Literature DB >> 15767453

Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation.

Daniel D Pinschewer1, Mar Perez, Juan Carlos de la Torre.   

Abstract

Each genome segment of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV), encodes two genes in ambisense orientation, separated by an intergenic region (IGR). The 3' ends of subgenomic viral mRNAs have been mapped to a stem-loop structure within the IGR, suggesting structure-dependent transcription termination. We have studied the role of the LCMV IGR by using a minigenome (MG) rescue system based on RNA analogues of the short genome segment. An ambisense MG coding for chloramphenicol acetyltransferase (CAT) and green fluorescent protein reporter genes instead of the nucleoprotein and glycoprotein open reading frames, respectively, served as a template for synthesis of full-length anti-MG (aMG) replicate and subgenomic size mRNA for reporter gene expression. An analogous MG without IGR was amplified by the virus polymerase with equal efficiency, but subgenomic mRNA was undetectable. Reporter gene expression from IGR-deficient aMG CAT-sense RNA of genomic length was approximately 5-fold less efficient than that from subgenomic CAT mRNA derived from an IGR-containing MG, but at least 100-fold more efficient than that from a T7 RNA polymerase transcript with the same sequence. Therefore, in the absence of IGR-mediated transcription termination, a fraction of full-length aMG RNA appears to behave as bona fide mRNA. Unexpectedly, MGs without IGR were dramatically impaired in their ability to passage reporter gene activity via infectious virus-like particles. These data suggest that the LCMV IGR serves individual functions in transcription termination for enhanced gene expression and in the virus assembly and/or budding, which are required for the efficient propagation of LCMV infectivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767453      PMCID: PMC1061552          DOI: 10.1128/JVI.79.7.4519-4526.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs.

Authors:  K J Lee; I S Novella; M N Teng; M B Oldstone; J C de La Torre
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome.

Authors:  T I Cornu; J C de la Torre
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.

Authors:  O Lenz; J ter Meulen; H D Klenk; N G Seidah; W Garten
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

4.  Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Authors:  Ki Jeong Lee; Mar Perez; Daniel D Pinschewer; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis.

Authors:  Tatjana I Cornu; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

6.  Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Mar Perez; Juan Carlos de la Torre
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Transcription and RNA replication of tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes.

Authors:  N López; R Jácamo; M T Franze-Fernández
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

8.  Arenavirus nucleocapsid protein displays a transcriptional antitermination activity in vivo.

Authors:  M A Tortorici; C G Albariño; D M Posik; P D Ghiringhelli; M E Lozano; R Rivera Pomar; V Romanowski
Journal:  Virus Res       Date:  2001-01       Impact factor: 3.303

9.  Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication.

Authors:  Daniel D Pinschewer; Mar Perez; Juan Carlos de la Torre
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

10.  Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.

Authors:  Daniel D Pinschewer; Mar Perez; Ana B Sanchez; Juan Carlos de la Torre
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

View more
  58 in total

1.  Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression.

Authors:  Andreas Bergthaler; Lukas Flatz; Ahmed N Hegazy; Susan Johnson; Edit Horvath; Max Löhning; Daniel D Pinschewer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence.

Authors:  Ana Grande-Pérez; Gema Gómez-Mariano; Pedro R Lowenstein; Esteban Domingo
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Genomic features of attenuated Junín virus vaccine strain candidate.

Authors:  Sandra Elizabeth Goñi; Javier Alonso Iserte; Ana Maria Ambrosio; Victor Romanowski; Pablo Daniel Ghiringhelli; Mario Enrique Lozano
Journal:  Virus Genes       Date:  2006-02       Impact factor: 2.332

4.  Genome comparison of virulent and avirulent strains of the Pichinde arenavirus.

Authors:  Shuiyun Lan; Lisa McLay; Judy Aronson; Hinh Ly; Yuying Liang
Journal:  Arch Virol       Date:  2008-05-28       Impact factor: 2.574

5.  Genomic and biological characterization of aggressive and docile strains of lymphocytic choriomeningitis virus rescued from a plasmid-based reverse-genetics system.

Authors:  Minjie Chen; Shuiyun Lan; Rong Ou; Graeme E Price; Hong Jiang; Juan Carlos de la Torre; Demetrius Moskophidis
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

6.  Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages.

Authors:  Xavier Carnec; Sylvain Baize; Stéphanie Reynard; Laure Diancourt; Valérie Caro; Noel Tordo; Michèle Bouloy
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

7.  Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.

Authors:  Benjamin W Neuman; Lydia H Bederka; David A Stein; Joey P C Ting; Hong M Moulton; Michael J Buchmeier
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

8.  Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (αβ/γ) receptor double knockout mice.

Authors:  Michael Patterson; Alexey Seregin; Cheng Huang; Olga Kolokoltsova; Jennifer Smith; Milagros Miller; Jeanon Smith; Nadezhda Yun; Allison Poussard; Ashley Grant; Bersabeh Tigabu; Aida Walker; Slobodan Paessler
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

9.  Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA.

Authors:  Lukas Flatz; Andreas Bergthaler; Juan Carlos de la Torre; Daniel D Pinschewer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

Review 10.  Reverse genetics approaches to combat pathogenic arenaviruses.

Authors:  Juan C de la Torre
Journal:  Antiviral Res       Date:  2008-09-07       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.